CONGRESSES
CONGRESSES
Find information on previous and upcoming congresses
View upcoming congresses and filter through abstracts, presentations, and posters from past congresses.
Upcoming congresses
2025 AMCP Nexus Congress
BioCryst will attend the 2025 AMCP Nexus Congress from Oct 27-30, 2025.
Browse our archive of congress materials
Filter
Showing 105 Materials
-
Suprachoroidal avoralstat, a plasma kallikrein inhibitor, stops vascular leakage in a well-established rabbit model
ASRS | 2025 | DME -
Burden of Treatment for Pediatric Patients (Aged Less Than 12 Years) With Hereditary Angioedema and Their Caregivers
HAEA National Summit | 2025 | HAE -
Patient Perspectives on the Importance of HAE Treatments
HAEA National Summit | 2025 | HAE -
HAE Attack Rates in Pediatric Patients 2 to <12 Years of Age with Prophylactic Berotralstat: Results from Interim Analysis of APeX-P
HAEA National Summit | 2025 | HAE -
Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results From APeX-P
EAACI | 2025 | HAE -
Assessment of the Effectiveness and Tolerability of Berotralstat for Long-term Prophylaxis in Hereditary Angioedema: Findings from the Berolife Study
EAACI | 2025 | HAE -
Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results From a Focus Group
EAACI | 2025 | HAE -
Impact of Berotralstat on Quality of Life in Patients with Hereditary Angioedema
EAACI | 2025 | HAE -
Berotralstat for the Prevention of Hereditary Angioedema Attacks: Results from the Italian Expanded Access Programme
C1-INH Def Wkshp | 2025 | HAE -
Tolerability and Effectiveness of Berotralstat for Prophylaxis in Adolescents with Hereditary Angioedema: Subgroup Analysis of the Berolife Study
C1-INH Def Wkshp | 2025 | HAE